Tevatiapine XR 50mg Quetiapine Fumarate Extended Release Tablets

Tevatiapine XR 50mg Quetiapine Fumarate Extended Release Tablets

Tevatiapine XR is a pharmaceutical product designed to address chemical imbalances in the brain, offering relief for conditions such as bipolar disorder, major depressive disorder, generalized anxiety disorder, and schizophrenia. This extended-release formulation ensures a steady release of the active ingredient, quetiapine fumarate, enhancing therapeutic efficacy and patient compliance.

Key Features

• Active Ingredient Quetiapine Fumarate
• Extended Release for Sustained Effect
• Indicated for Bipolar Disorder, Schizophrenia, and Depression

Technical Specifications

• Strength 50mg
• Formulation Extended Release Tablet

Application or Use Case

Tevatiapine XR is primarily used in the management of psychiatric conditions, providing a reliable option for patients requiring long-term treatment.

Typical User/Industry Profile

Healthcare providers specializing in psychiatry and mental health, as well as patients diagnosed with the aforementioned conditions.